Characterization of central venous catheter–associated deep venous thrombosis in infants
| Autor: | Lauren Stephens, Robert A. Drongowski, Brian W. Gray, George B. Mychaliska, Kavita Warrier, Steven W. Pipe, Raquel Gonzalez |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
Catheterization Central Venous medicine.medical_specialty Percutaneous medicine.medical_treatment Comorbidity Subclavian Vein Risk Factors Upper Extremity Deep Vein Thrombosis Humans Medicine Catheter removal cardiovascular diseases Retrospective Studies Ultrasonography Venous Thrombosis business.industry Incidence Incidence (epidemiology) Infant Retrospective cohort study Phlebography General Medicine Femoral Vein Length of Stay Hospitals Pediatric medicine.disease Surgery Intensive Care Units Venous thrombosis Pediatrics Perinatology and Child Health Female Jugular Veins business Complication Risk Reduction Behavior Central venous catheter |
| Zdroj: | Journal of Pediatric Surgery. 47:1159-1166 |
| ISSN: | 0022-3468 |
| DOI: | 10.1016/j.jpedsurg.2012.03.043 |
| Popis: | Deep venous thrombosis (DVT) is a frequent complication in infants with central venous catheters (CVCs). We performed this study to identify risk factors and risk-reduction strategies of CVC-associated DVT in infants.Infants younger than 1 year who had a CVC placed at our center from 2005 to 2009 were reviewed. Patients with ultrasonically diagnosed DVT were compared to those without radiographic evidence.Of 333 patients, 47% (155/333) had femoral, 33% (111/333) had jugular, and 19% (64/333) had subclavian CVCs. Deep venous thromboses occurred in 18% (60/333) of patients. Sixty percent (36/60) of DVTs were in femoral veins. Femoral CVCs were associated with greater DVT rates (27%; 42/155) than jugular (11%; 12/111) or subclavian CVCs (9%; 6/64; P.01). There was a 16% DVT rate in those with saphenofemoral Broviac CVCs vs 83% (20/24) in those with percutaneous femoral lines (P.01). Multilumen CVCs had higher DVT rates than did single-lumen CVCs (54% vs 6%, P.01), and mean catheter days before DVT diagnosis was shorter for percutaneous lines than Broviacs (13 ± 17 days vs 30 ± 37 days, P = .02). Patients with +DVT had longer length of stay (86 ± 88 days vs 48 ± 48 days, P.01) and higher percentage of intensive care unit admission (82% vs 70%, P = .02).Deep venous thrombosis reduction strategies in infants with CVCs include avoiding percutaneous femoral and multilumen CVCs, screening percutaneous lines, and early catheter removal. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect